| Title: | Clinical associate professor |
| Address: | CHUM 1051 Sanguinet, pavillon F, 6e étage Montréal, H2X 3E4 |
| Room: | 1102E |
| Email: | valerie.martel-laferriere@umontreal.ca |
Biography
To come up
Team
NA
Themes
- Hepatitis C
- HIV
- People using injection drugs
Research topics
To come up
Publications
- Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017.
Murphy DG, Dion R, Simard M, Vachon ML, Martel-Laferrière V, Serhir B, Longtin J.
Can Commun Dis Rep. 2019 Sep 5;45(9):230-237. doi: 10.14745/ccdr.v45i09a02. eCollection 2019 Sep 5. - Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study.
Martel-Laferrière V, Nitulescu R, Cox J, Cooper C, Tyndall M, Rouleau D, Walmsley S, Wong L, Klein MB; Canadian Co-infection Cohort Study Investigators.
BMC Infect Dis. 2017 Jan 17;17(1):80 - Virological response rates for telaprevir-based hepatitis C triple therapy in patients with and without HIV coinfection.
Martel-Laferrière V, Brinkley S, Bichoupan K, Posner S, Stivala A, Perumalswami P, Schiano T, Sulkowski M, Dieterich D, Branch A.; HIV Med. 2014 Feb;15(2):108-15. doi: 10.1111/hiv.12086. Epub 2013 Sep 11.